[Bullous skin diseases].
Ugeskr Laeger
; 184(41)2022 10 10.
Article
in Da
| MEDLINE
| ID: mdl-36254827
ABSTRACT
This review finds that topical corticosteroids and systemic corticosteroids are the mainstays of initial treatment for bullous pemphigoid and pemphigus diseases. Additional immunomodulatory therapies such as methotrexate, azathioprine and mycophenolatmofetil should be added early during treatment to minimize the adverse effects of chronic corticosteroid therapy and to augment improvement in the disease. Rituximab is a first-line immunomodulatory treatment for moderate to severe pemphigus disease.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Skin Diseases, Vesiculobullous
/
Pemphigus
Limits:
Humans
Language:
Da
Journal:
Ugeskr Laeger
Year:
2022
Document type:
Article